December 2008 Briefing - Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for December 2008. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Longer Radiation Delay Improves Glioblastoma Survival
WEDNESDAY, Dec. 31 (HealthDay News) -- Glioblastoma patients who wait four to six weeks after surgery before starting radiation treatment have better survival than patients who start sooner, according to a study published online Dec. 29 in the Journal of Clinical Oncology.
Chemoembolization Helps to Treat Liver Metastases
TUESDAY, Dec. 30 (HealthDay News) -- Repeated transarterial chemoembolization is an effective treatment for neoadjuvant, symptomatic or palliative treatment of liver metastases originating from colorectal cancer, according to the results of a study published in the January issue of Radiology.
Added Measurement Improves Carpel Tunnel Diagnosis
TUESDAY, Dec. 30 (HealthDay News) -- Accuracy of diagnosis of carpel tunnel syndrome is improved by calculating the difference between the carpel tunnel cross-sectional area and the proximal cross-sectional area, instead of just the carpel tunnel cross-sectional area alone, according to research published in the January issue of Radiology.
Imaging Combo Increases Prostate Cancer Detection
MONDAY, Dec. 29 (HealthDay News) -- Combining an apparent diffusion coefficient map reading with T2-weighted MRIs improves their diagnostic capability for prostate cancer detection, according to research published in the January issue of Radiology.
Imaging Tool Useful in Lumbar Stenosis
MONDAY, Dec. 22 (HealthDay News) -- Magnetic resonance myelography (MRM) appears to be a useful way of improving the accuracy of MRI in assessing multiple lumbar stenosis, researchers report in the December issue of the Journal of Spinal Disorders & Techniques.
Emergency Catheterization OK in Contrast Allergic Patients
MONDAY, Dec. 1 (HealthDay News) -- Patients with a history of contrast allergy can safely undergo emergency catheterization for ST-segment elevation myocardial infarction if pretreated, according to a report in the Dec. 1 issue of the American Journal of Cardiology.